-
1
-
-
0027478285
-
Meta-analysis of the effectiveness of current drug therapy of ulcerative colitis
-
Kornbluth AA, Salomon P, Sacks HS, et al. Meta-analysis of the effectiveness of current drug therapy of ulcerative colitis. J Clin Gastroenterol 1993;16:215-8.
-
(1993)
J Clin Gastroenterol
, vol.16
, pp. 215-218
-
-
Kornbluth, A.A.1
Salomon, P.2
Sacks, H.S.3
-
2
-
-
0024602611
-
The "Natural History" of ulcerative colitis: An analysis of the placebo response
-
Meyers S, Janowitz HD. The "Natural History" of ulcerative colitis: An analysis of the placebo response. Am J Gastroenterol 1989;11: 33-7.
-
(1989)
Am J Gastroenterol
, vol.11
, pp. 33-37
-
-
Meyers, S.1
Janowitz, H.D.2
-
4
-
-
0038811981
-
Endoscopy in inflammatory bowel disease
-
Kirsner JD, Shorter RG, ed. Philadelphia: Lea and Fabiger
-
Waye JD. Endoscopy in inflammatory bowel disease. In: Kirsner JD, Shorter RG, ed. Inflammatory bowel disease. Philadelphia: Lea and Fabiger, 1988, pp 353-76.
-
(1988)
Inflammatory Bowel Disease
, pp. 353-376
-
-
Waye, J.D.1
-
5
-
-
0021364710
-
Rectal biopsy helps to distinguish acute self-limited colitis from idiopathic inflammatory bowel disease
-
Surawicz SM, Belic L. Rectal biopsy helps to distinguish acute self-limited colitis from idiopathic inflammatory bowel disease. Gastroenterology 1984;86:104-13.
-
(1984)
Gastroenterology
, vol.86
, pp. 104-113
-
-
Surawicz, S.M.1
Belic, L.2
-
6
-
-
0023073487
-
Histopathology differentiates self-limited colitis from ulcerative colitis
-
Nostrant TT, Kumar NB, Appelman HD. Histopathology differentiates self-limited colitis from ulcerative colitis. Gastroenterology 1987;92:318-28.
-
(1987)
Gastroenterology
, vol.92
, pp. 318-328
-
-
Nostrant, T.T.1
Kumar, N.B.2
Appelman, H.D.3
-
7
-
-
0038135267
-
Differential diagnosis of colitis
-
Targan SR, Shanahan R, eds. From Bench to Bedside. Baltimore: Williams and Wilkins
-
Surawicz CM. Differential diagnosis of colitis. In: Targan SR, Shanahan R, eds. Inflammatory Bowel Disease. From Bench to Bedside. Baltimore: Williams and Wilkins, 1994; pp 409-28.
-
(1994)
Inflammatory Bowel Disease
, pp. 409-428
-
-
Surawicz, C.M.1
-
8
-
-
0008690916
-
Cortisone in ulcerative colitis. Final report on a therapeutic trial
-
Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J 1955;2:1041-5.
-
(1955)
Br Med J
, vol.2
, pp. 1041-1045
-
-
Truelove, S.C.1
Witts, L.J.2
-
9
-
-
0027534577
-
Sulfasalazine revisited: A meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis
-
Sutherland LR, May GR, Shaffer EA. Sulfasalazine revisited: A meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis. Ann Intern Med 1993;118:540-9.
-
(1993)
Ann Intern Med
, vol.118
, pp. 540-549
-
-
Sutherland, L.R.1
May, G.R.2
Shaffer, E.A.3
-
10
-
-
0027236393
-
Medical therapy of ulcerative colitis
-
Hanauer SB. Medical therapy of ulcerative colitis. Lancet 1993;1: 412-7.
-
(1993)
Lancet
, vol.1
, pp. 412-417
-
-
Hanauer, S.B.1
-
11
-
-
50549187947
-
Sulphasalazine and salicylazophadimidine in ulcerative colitis
-
Baron JH, Connell JE, Lennard-Jones J, et al. Sulphasalazine and salicylazophadimidine in ulcerative colitis. Lancet 1962;1:1094-6.
-
(1962)
Lancet
, vol.1
, pp. 1094-1096
-
-
Baron, J.H.1
Connell, J.E.2
Lennard-Jones, J.3
-
12
-
-
84883845710
-
Controlled trial of sulphasalazine in the treatment of ulcerative colitis
-
Dick AP, Grayson MJ, Carpenter RG, et al. Controlled trial of sulphasalazine in the treatment of ulcerative colitis. Gut 1964;5:437-42.
-
(1964)
Gut
, vol.5
, pp. 437-442
-
-
Dick, A.P.1
Grayson, M.J.2
Carpenter, R.G.3
-
13
-
-
0025779674
-
Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis: A multi-center study
-
Sninsky CA, Cort DH, Shanahan F, et al. Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis: A multi-center study. Ann Intern Med 1991;115:350-5.
-
(1991)
Ann Intern Med
, vol.115
, pp. 350-355
-
-
Sninsky, C.A.1
Cort, D.H.2
Shanahan, F.3
-
14
-
-
0023521441
-
Coated oral 5-aminosalicylic therapy for mildly to moderately ulcerative colitis: A randomized trial
-
Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic therapy for mildly to moderately ulcerative colitis: A randomized trial. N Engl J Med 1987;317:1625-9.
-
(1987)
N Engl J Med
, vol.317
, pp. 1625-1629
-
-
Schroeder, K.W.1
Tremaine, W.J.2
Ilstrup, D.M.3
-
15
-
-
0025364388
-
Double-blind, placebo-controlled study of olsalazine in the treatment of ulcerative colitis
-
Zinberg J, Molinas S, Das KM. Double-blind, placebo-controlled study of olsalazine in the treatment of ulcerative colitis. Am J Gastroenterol 1990;85:562-6.
-
(1990)
Am J Gastroenterol
, vol.85
, pp. 562-566
-
-
Zinberg, J.1
Molinas, S.2
Das, K.M.3
-
16
-
-
0024433044
-
Olsalazine versus placebo in the treatment of mild-moderate ulcerative colitis: A randomized double-blind trial
-
Feurle GE, Theuer D, Velasco S, et al. Olsalazine versus placebo in the treatment of mild-moderate ulcerative colitis: A randomized double-blind trial. Gut 1989;30:1354-61.
-
(1989)
Gut
, vol.30
, pp. 1354-1361
-
-
Feurle, G.E.1
Theuer, D.2
Velasco, S.3
-
17
-
-
0024359916
-
Olsalazine or sulphasalazine in first attacks of ulcerative colitis? a double-blind study
-
Rao SS, Dundas SA, Holdsworth CD, et al. Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double-blind study. Gut 1989;30:675-9.
-
(1989)
Gut
, vol.30
, pp. 675-679
-
-
Rao, S.S.1
Dundas, S.A.2
Holdsworth, C.D.3
-
18
-
-
0023618491
-
Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine: A prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial
-
Meyers S, Sachar DB, Present DH, et al. Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine: A prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial. Gastroenterology 1987;93:2255-62.
-
(1987)
Gastroenterology
, vol.93
, pp. 2255-2262
-
-
Meyers, S.1
Sachar, D.B.2
Present, D.H.3
-
19
-
-
0023136492
-
Clinical experience of the tolerance of mesalazine and olsalazine in patients intolerant to sulfasalazine
-
Rao SS, Cann PA, Holdsworth CD. Clinical experience of the tolerance of mesalazine and olsalazine in patients intolerant to sulfasalazine. Scand J Gastroenterol 1987;22:332-7.
-
(1987)
Scand J Gastroenterol
, vol.22
, pp. 332-337
-
-
Rao, S.S.1
Cann, P.A.2
Holdsworth, C.D.3
-
20
-
-
0026530975
-
Clinical tolerance to three 5-aminosalicylic acid releasing preparations in patients with inflammatory bowel disease intolerant or allergic to sulfasalazine
-
Giaffer MH, O'Brien CJ, Holdsworth CD. Clinical tolerance to three 5-aminosalicylic acid releasing preparations in patients with inflammatory bowel disease intolerant or allergic to sulfasalazine. Aliment Pharmacol Ther 1992;6:51-61.
-
(1992)
Aliment Pharmacol Ther
, vol.6
, pp. 51-61
-
-
Giaffer, M.H.1
O'Brien, C.J.2
Holdsworth, C.D.3
-
21
-
-
0025322421
-
Mesalazine (5-ASA) suppositories in the treatment of ulcerative proctitis or distal proctosigmoiditis
-
Campieri M, Defranchis R, Bianchi G, et al. Mesalazine (5-ASA) suppositories in the treatment of ulcerative proctitis or distal proctosigmoiditis. Scand J. Gastroenterol 1990;25:663-8.
-
(1990)
Scand J. Gastroenterol
, vol.25
, pp. 663-668
-
-
Campieri, M.1
Defranchis, R.2
Bianchi, G.3
-
22
-
-
0025049819
-
5-aminosalicylic acid suppositories in the maintenance of remission in idiopathic proctitis or proctosigmoiditis: A double-blind placebo controlled clinical trial
-
D'Arienzo A, Panarese A, D'Armiento FP, et al. 5-aminosalicylic acid suppositories in the maintenance of remission in idiopathic proctitis or proctosigmoiditis: A double-blind placebo controlled clinical trial. Am J Gastroenterol 1990;85:1079-82.
-
(1990)
Am J Gastroenterol
, vol.85
, pp. 1079-1082
-
-
D'Arienzo, A.1
Panarese, A.2
D'Armiento, F.P.3
-
23
-
-
0023221030
-
5-aminosalicylic acid enemas in the treatment of distal ulcerative colitis, proctosigmoiditis and proctitis
-
Sutherland LR, Martin F, Greer S, et al. 5-aminosalicylic acid enemas in the treatment of distal ulcerative colitis, proctosigmoiditis and proctitis. Gastroenterology 1987;92:1894-8.
-
(1987)
Gastroenterology
, vol.92
, pp. 1894-1898
-
-
Sutherland, L.R.1
Martin, F.2
Greer, S.3
-
24
-
-
0023614327
-
5-aminosalicylic acid enemas in the maintenance of remission in distal ulcerative colitis and proctitis
-
Sutherland LR, Martin F. 5-aminosalicylic acid enemas in the maintenance of remission in distal ulcerative colitis and proctitis. Am J Gastroenterol 1987;1:3-6.
-
(1987)
Am J Gastroenterol
, vol.1
, pp. 3-6
-
-
Sutherland, L.R.1
Martin, F.2
-
25
-
-
0025359098
-
Intermittent therapy with high dose 5-aminosalicylic acid enemas for maintaining remission in ulcerative proctosigmoiditis
-
D'Albasio G, Trallori G, Ghetti A, et al. Intermittent therapy with high dose 5-aminosalicylic acid enemas for maintaining remission in ulcerative proctosigmoiditis. Dis Colon Rectum 1990;33:394-7.
-
(1990)
Dis Colon Rectum
, vol.33
, pp. 394-397
-
-
D'Albasio, G.1
Trallori, G.2
Ghetti, A.3
-
26
-
-
7144260013
-
Topical aminosalicylic (ASA) therapy for distal ulcerative colitis: A meta-analysis
-
abstract
-
Marshall JK, Irvine FJ. Topical aminosalicylic (ASA) therapy for distal ulcerative colitis: A meta-analysis. Gastroenterology 1994;106: A1037 (abstract).
-
(1994)
Gastroenterology
, vol.106
-
-
Marshall, J.K.1
Irvine, F.J.2
-
27
-
-
0023876851
-
5-aminosalicylic acid enemas: Effective agent in maintaining remission in left-sided ulcerative colitis
-
Biddle WL, Greenberger NJ, Swan JT, et al. 5-aminosalicylic acid enemas: Effective agent in maintaining remission in left-sided ulcerative colitis. Gastroenterology 1988;94:1075-9.
-
(1988)
Gastroenterology
, vol.94
, pp. 1075-1079
-
-
Biddle, W.L.1
Greenberger, N.J.2
Swan, J.T.3
-
28
-
-
0025169657
-
Topical treatment of ulcerative colitis
-
Sutherland LR. Topical treatment of ulcerative colitis. Med Clin North Am 1990;74:119-31.
-
(1990)
Med Clin North Am
, vol.74
, pp. 119-131
-
-
Sutherland, L.R.1
-
29
-
-
0001099178
-
Treatment of ulcerative colitis with topical hydrocortisone hemisuccinate
-
Watkinson G. Treatment of ulcerative colitis with topical hydrocortisone hemisuccinate. Br Med J 1958;2:1077-82.
-
(1958)
Br Med J
, vol.2
, pp. 1077-1082
-
-
Watkinson, G.1
-
30
-
-
0001099179
-
Treatment of ulcerative colitis with local hemisuccinate sodium: A report on a controlled clinical trial
-
Truelove SC, Treatment of ulcerative colitis with local hemisuccinate sodium: A report on a controlled clinical trial. Br Med J 1958;2: 1072-7.
-
(1958)
Br Med J
, vol.2
, pp. 1072-1077
-
-
Truelove, S.C.1
-
31
-
-
0019467018
-
Treatment of ulcerative colitis with high dose 5-ASA enemas
-
Campiere M, Lanfranchi GA, Bazzochi G, et al. Treatment of ulcerative colitis with high dose 5-ASA enemas. Lancet 1981;2:270-3.
-
(1981)
Lancet
, vol.2
, pp. 270-273
-
-
Campiere, M.1
Lanfranchi, G.A.2
Bazzochi, G.3
-
32
-
-
0022540098
-
5-ASA enemas in refractory distal ulcerative colitis: A randomized controlled trial
-
Friedman LS, Richter JM, Kirkham SE, et al. 5-ASA enemas in refractory distal ulcerative colitis: A randomized controlled trial. Am J Gastro 1986;81:412-6.
-
(1986)
Am J Gastro
, vol.81
, pp. 412-416
-
-
Friedman, L.S.1
Richter, J.M.2
Kirkham, S.E.3
-
33
-
-
0008337302
-
Budesonide in distal colitis
-
Danish Budesonide Study Group. Budesonide in distal colitis. Scand J Gastroenterol 1991;26:1225-9.
-
(1991)
Scand J Gastroenterol
, vol.26
, pp. 1225-1229
-
-
-
34
-
-
0018728379
-
Retrograde spread of hydrocortisone-containing foam given intrarectally in ulcerative colitis
-
Farthing JJ, Rutland JD, Clar JL. Retrograde spread of hydrocortisone-containing foam given intrarectally in ulcerative colitis. Br Med J 1979;2:1822-7.
-
(1979)
Br Med J
, vol.2
, pp. 1822-1827
-
-
Farthing, J.J.1
Rutland, J.D.2
Clar, J.L.3
-
35
-
-
0022625839
-
Retrograde spreading of hydrocortisone enema in inflammatory bowel disease
-
Jay M. Retrograde spreading of hydrocortisone enema in inflammatory bowel disease. Dig Dis Sci 1986;31:139-44.
-
(1986)
Dig Dis Sci
, vol.31
, pp. 139-144
-
-
Jay, M.1
-
36
-
-
0026587640
-
Distribution of mesalamine enemas in patients with active distal ulcerative colitis
-
Chapman NJ. Distribution of mesalamine enemas in patients with active distal ulcerative colitis. Mayo Clin Proc 1992;67:245-8.
-
(1992)
Mayo Clin Proc
, vol.67
, pp. 245-248
-
-
Chapman, N.J.1
-
37
-
-
0022540098
-
5-ASA enemas in refractory distal ulcerative colitis: A randomized controlled trial
-
Friedman LS, Richter JM, Kirkham SE, et al. 5-ASA enemas in refractory distal ulcerative colitis: A randomized controlled trial. Am J Gastroenterol 1986;81:412-6.
-
(1986)
Am J Gastroenterol
, vol.81
, pp. 412-416
-
-
Friedman, L.S.1
Richter, J.M.2
Kirkham, S.E.3
-
38
-
-
0027292761
-
Mesalamine capsules (Pentasa) for treatment of active ulcerative colitis: Results of a controlled trial
-
Hanauer SB, Schwartz J, Robinson M, et al. Mesalamine capsules (Pentasa) for treatment of active ulcerative colitis: Results of a controlled trial. Am J Gastroenterol 1993;88:1188-97.
-
(1993)
Am J Gastroenterol
, vol.88
, pp. 1188-1197
-
-
Hanauer, S.B.1
Schwartz, J.2
Robinson, M.3
-
39
-
-
0024268809
-
Double-blind comparison of olsalazine and sulfasalazine in active ulcerative colitis
-
Willoughby CP, Cowan RE, Gould SR. Double-blind comparison of olsalazine and sulfasalazine in active ulcerative colitis. Scand J Gastroenterol (suppl) 1988;148:40-4.
-
(1988)
Scand J Gastroenterol (Suppl)
, vol.148
, pp. 40-44
-
-
Willoughby, C.P.1
Cowan, R.E.2
Gould, S.R.3
-
40
-
-
0008690916
-
Cortisone in ulcerative colitis: Report on a therapeutic trial
-
Truelove SC, Witts IJ. Cortisone in ulcerative colitis: Report on a therapeutic trial. Br Med J 1955;2:1041-9.
-
(1955)
Br Med J
, vol.2
, pp. 1041-1049
-
-
Truelove, S.C.1
Witts, I.J.2
-
41
-
-
0000206329
-
An assessment of prednisone, salazopyrine, and topical hydrocortisone hemisuccinate used as outpatient treatment for ulcerative colitis
-
Lennard-Jones JE. An assessment of prednisone, salazopyrine, and topical hydrocortisone hemisuccinate used as outpatient treatment for ulcerative colitis. Gut 1960;1:217-22.
-
(1960)
Gut
, vol.1
, pp. 217-222
-
-
Lennard-Jones, J.E.1
-
42
-
-
0000766395
-
Outpatient treatment of ulcerative colitis
-
Baron JH. Outpatient treatment of ulcerative colitis. Br Med J 1962; 2:441-4.
-
(1962)
Br Med J
, vol.2
, pp. 441-444
-
-
Baron, J.H.1
-
44
-
-
0020048415
-
Controlled trial of azathioprine in chronic ulcerative colitis
-
Kirk AP, Lennard-Jones JE. Controlled trial of azathioprine in chronic ulcerative colitis. Br Med J 1982;284:1291-2.
-
(1982)
Br Med J
, vol.284
, pp. 1291-1292
-
-
Kirk, A.P.1
Lennard-Jones, J.E.2
-
45
-
-
0009321827
-
A controlled trial of azathropine in the treatment of chronic ulcerative colitis
-
Rosenberg JL, Wall AJ, Settles RH, et al. A controlled trial of azathropine in the treatment of chronic ulcerative colitis. Gastroenterology 1973;64:793-801.
-
(1973)
Gastroenterology
, vol.64
, pp. 793-801
-
-
Rosenberg, J.L.1
Wall, A.J.2
Settles, R.H.3
-
46
-
-
0008700092
-
6-mercaptopurine is an effective steroid-sparing agent in the treatment of refractory ulcerative colitis
-
abstract
-
Liang LC, Rubin PH, Bodian G, et al. 6-mercaptopurine is an effective steroid-sparing agent in the treatment of refractory ulcerative colitis. Gastroenterology 1992;102:A653 (abstract).
-
(1992)
Gastroenterology
, vol.102
-
-
Liang, L.C.1
Rubin, P.H.2
Bodian, G.3
-
47
-
-
0025330168
-
The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis
-
Adler DJ, Korelitz BI. The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis. Am J Gastroenterol 1990;85:717-22.
-
(1990)
Am J Gastroenterol
, vol.85
, pp. 717-722
-
-
Adler, D.J.1
Korelitz, B.I.2
-
48
-
-
0025310957
-
The role of azathioprine in the management of ulcerative colitis
-
Lobo AJ, Foster PN, Burke D, et al. The role of azathioprine in the management of ulcerative colitis. Dis Colon Rectum 1990;33:374-7.
-
(1990)
Dis Colon Rectum
, vol.33
, pp. 374-377
-
-
Lobo, A.J.1
Foster, P.N.2
Burke, D.3
-
49
-
-
0026693139
-
Randomized controlled trial of azathioprine withdrawal in ulcerative colitis
-
Hawthorne AB, Logan RFA, Hawkey CJ, et al. Randomized controlled trial of azathioprine withdrawal in ulcerative colitis. Br Med J 1992;305:20-2.
-
(1992)
Br Med J
, vol.305
, pp. 20-22
-
-
Hawthorne, A.B.1
Logan, R.F.A.2
Hawkey, C.J.3
-
50
-
-
0029817846
-
The long-term outcome of ulcerative colitis treated with 6-Mercaptopurine
-
George J, Present DH, Pou R, et al. The long-term outcome of ulcerative colitis treated with 6-Mercaptopurine. Am J Gastroenterol 1996;91:1711-4.
-
(1996)
Am J Gastroenterol
, vol.91
, pp. 1711-1714
-
-
George, J.1
Present, D.H.2
Pou, R.3
-
51
-
-
49749207893
-
Controlled trial of sulphasalazine in maintenance therapy for ulcerative colitis
-
Misiewicz JJ, Lennard-Jones JE, Connell AM, et al. Controlled trial of sulphasalazine in maintenance therapy for ulcerative colitis. Lancet 1965;1:185-8.
-
(1965)
Lancet
, vol.1
, pp. 185-188
-
-
Misiewicz, J.J.1
Lennard-Jones, J.E.2
Connell, A.M.3
-
52
-
-
0015724539
-
A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine (Salazopyrin)
-
Dissanayake AS, Truelove SC. A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine (Salazopyrin). Gut 1973;14:923-6.
-
(1973)
Gut
, vol.14
, pp. 923-926
-
-
Dissanayake, A.S.1
Truelove, S.C.2
-
53
-
-
0018836339
-
Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis
-
Azad Khan AK, Howes DT, Piris J, et al. Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis. Gut 1980; 21:232-40.
-
(1980)
Gut
, vol.21
, pp. 232-240
-
-
Azad Khan, A.K.1
Howes, D.T.2
Piris, J.3
-
54
-
-
0022649415
-
Azodisal sodium in the treatment of ulcerative colitis: A study of tolerance and relapse-prevention properties
-
Sandberg-Gertzen H, Jarnerot G, Draaz W. Azodisal sodium in the treatment of ulcerative colitis: A study of tolerance and relapse-prevention properties. Gastroenterology 1986;90:1024-30.
-
(1986)
Gastroenterology
, vol.90
, pp. 1024-1030
-
-
Sandberg-Gertzen, H.1
Jarnerot, G.2
Draaz, W.3
-
55
-
-
0023629045
-
Olsalzine in patients intolerant of SASP
-
Ireland A, Jewell DP. Olsalzine in patients intolerant of SASP. Scand J Gastroenterol 1989;22:1038-40.
-
(1989)
Scand J Gastroenterol
, vol.22
, pp. 1038-1040
-
-
Ireland, A.1
Jewell, D.P.2
-
56
-
-
0023920745
-
Comparison of delayed release 5-aminosalicylic acid, (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis
-
Riley SA, Mani V, Goodman MJ, et al. Comparison of delayed release 5-aminosalicylic acid, (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis. Gut 1988;29: 669-74.
-
(1988)
Gut
, vol.29
, pp. 669-674
-
-
Riley, S.A.1
Mani, V.2
Goodman, M.J.3
-
57
-
-
0019972694
-
Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid
-
Dew MJ, Hughes P, Harries AD, et al. Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid. Br Med J 1982;285:1012-4.
-
(1982)
Br Med J
, vol.285
, pp. 1012-1014
-
-
Dew, M.J.1
Hughes, P.2
Harries, A.D.3
-
58
-
-
0020560697
-
Maintenance of remission in ulcerative colitis with 5-aminosalicylic acid in high doses by mouth
-
Dew MJ, Harries AD, Evans N, et al. Maintenance of remission in ulcerative colitis with 5-aminosalicylic acid in high doses by mouth. Br Med J 1983;287:413-5.
-
(1983)
Br Med J
, vol.287
, pp. 413-415
-
-
Dew, M.J.1
Harries, A.D.2
Evans, N.3
-
59
-
-
0023906720
-
Comparison of delayed release 5-aminosalicylic acid (mesalazine) and sulphasalazine as maintenance treatment for patients with ulcerative colitis
-
Riley SA, Mani V, Goodman MJ, et al. Comparison of delayed release 5-aminosalicylic acid (mesalazine) and sulphasalazine as maintenance treatment for patients with ulcerative colitis. Gastroenterology 1988;94:1383-9.
-
(1988)
Gastroenterology
, vol.94
, pp. 1383-1389
-
-
Riley, S.A.1
Mani, V.2
Goodman, M.J.3
-
60
-
-
0024208726
-
Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis
-
Mulder CJJ, Tytgat GN, Weterman IT, et al. Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis. Gastroenterology 1988;95:1449-53.
-
(1988)
Gastroenterology
, vol.95
, pp. 1449-1453
-
-
Mulder, C.J.J.1
Tytgat, G.N.2
Weterman, I.T.3
-
61
-
-
0024951547
-
Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis
-
Rutgeerts P. Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 1989;3:183-91.
-
(1989)
Aliment Pharmacol Ther
, vol.3
, pp. 183-191
-
-
Rutgeerts, P.1
-
62
-
-
4043130484
-
Comparison of mesalazine with sulphasalazine in prophylactic treatment of ulcerative colitis
-
abstract
-
Bianchi Porro G, Ardizzone S, Fasoli R, et al. Comparison of mesalazine with sulphasalazine in prophylactic treatment of ulcerative colitis. Gut 1989;30:A1467 (abstract).
-
(1989)
Gut
, vol.30
-
-
Bianchi Porro, G.1
Ardizzone, S.2
Fasoli, R.3
-
63
-
-
0025058676
-
Pentasa in maintenance treatment of ulcerative colitis
-
letter
-
Gionchetti P, Campieri M, Beluzzi A, et al. Pentasa in maintenance treatment of ulcerative colitis. Gastroenterology 1990;98:251-5 (letter).
-
(1990)
Gastroenterology
, vol.98
, pp. 251-255
-
-
Gionchetti, P.1
Campieri, M.2
Beluzzi, A.3
-
64
-
-
0026671294
-
Comparison doses of balsalazide in maintaining ulcerative colitis in remission over 12 months
-
Green JRB, Swan CHJ, Rowlinson A, et al. Comparison doses of balsalazide in maintaining ulcerative colitis in remission over 12 months. Aliment Pharmacol Ther 1992;6:647-52.
-
(1992)
Aliment Pharmacol Ther
, vol.6
, pp. 647-652
-
-
Green, J.R.B.1
Swan, C.H.J.2
Rowlinson, A.3
-
65
-
-
0028932679
-
Maintenance therapy in ulcerative colitis and Crohn's disease
-
in press
-
Sachar DB. Maintenance therapy in ulcerative colitis and Crohn's disease. J Clin Gastroenterol (in press).
-
J Clin Gastroenterol
-
-
Sachar, D.B.1
-
66
-
-
0028804562
-
Safety and efficacy of controlled release mesalamine for maintenance of remission in ulcerative colitis
-
Miner P, Hanauer S, Robinson M, et al. Safety and efficacy of controlled release mesalamine for maintenance of remission in ulcerative colitis. Dig Dis Sci 1995;40:296-304.
-
(1995)
Dig Dis Sci
, vol.40
, pp. 296-304
-
-
Miner, P.1
Hanauer, S.2
Robinson, M.3
-
67
-
-
0023921849
-
Controlled trial comparing olsalazine and sulphasalazine for the maintenance of ulcerative colitis
-
Ireland A, Mason CH, Jewell DP. Controlled trial comparing olsalazine and sulphasalazine for the maintenance of ulcerative colitis. Gut 1988;29:835-7.
-
(1988)
Gut
, vol.29
, pp. 835-837
-
-
Ireland, A.1
Mason, C.H.2
Jewell, D.P.3
-
68
-
-
0026595483
-
Prophylactic effects of olsalazine v sulphasalazine during 12 months of maintenance treatment of ulcerative colitis
-
Killerich S, Ladefoged K, Rennem T, et al. Prophylactic effects of olsalazine v sulphasalazine during 12 months of maintenance treatment of ulcerative colitis. Gut 1992;33:252-5.
-
(1992)
Gut
, vol.33
, pp. 252-255
-
-
Killerich, S.1
Ladefoged, K.2
Rennem, T.3
-
69
-
-
0026552099
-
Relapse-preventing effect and safety of sulfasalazine and olsalazine in patients with ulcerative colitis in remission: A prospective, double-blind, randomized multicenter trial
-
Rijk MCM, Van Lier HJJ, van Tongeren JHM. Relapse-preventing effect and safety of sulfasalazine and olsalazine in patients with ulcerative colitis in remission: A prospective, double-blind, randomized multicenter trial. Am J Gastroenterol 1992;87:438-42.
-
(1992)
Am J Gastroenterol
, vol.87
, pp. 438-442
-
-
Rijk, M.C.M.1
Van Lier, H.J.J.2
Van Tongeren, J.H.M.3
-
70
-
-
0024028317
-
Balasalzide in the maintenance treatment of patients with ulcerative colitis: A double-blind comparison with sulphasalazine
-
McIntyre P, Rodriges CA, Lennard-Jones JE, et al. Balasalzide in the maintenance treatment of patients with ulcerative colitis: A double-blind comparison with sulphasalazine. Aliment Pharmacol Ther 1988;2:237-43.
-
(1988)
Aliment Pharmacol Ther
, vol.2
, pp. 237-243
-
-
McIntyre, P.1
Rodriges, C.A.2
Lennard-Jones, J.E.3
-
71
-
-
0024951547
-
Comparative efficacy of coated, oral 5-aminosalicylic acid (claversal) and sulphasalazine for maintaining remission of ulcerative colitis
-
Rutgeerts P. Comparative efficacy of coated, oral 5-aminosalicylic acid (claversal) and sulphasalazine for maintaining remission of ulcerative colitis. International Study Group. Aliment Pharmacol Ther 1989;3:183-91.
-
(1989)
International Study Group. Aliment Pharmacol Ther
, vol.3
, pp. 183-191
-
-
Rutgeerts, P.1
-
72
-
-
4043093704
-
A dose-ranging study of olsalazine in ulcerative colitis
-
Travis SPL, Tysk C, Jarnerot G, et al. A dose-ranging study of olsalazine in ulcerative colitis. Gut 1992;33:546-9.
-
(1992)
Gut
, vol.33
, pp. 546-549
-
-
Travis, S.P.L.1
Tysk, C.2
Jarnerot, G.3
-
73
-
-
0026744456
-
Improved maintenance of remission in ulcerative colitis by balsalazide 4G/day compared to 2G/day
-
Giaffer H, Holdsworth CD, Lennard-Jones JE, et al. Improved maintenance of remission in ulcerative colitis by balsalazide 4G/day compared to 2G/day. Aliment Pharmacol Ther 1992;6:479-85.
-
(1992)
Aliment Pharmacol Ther
, vol.6
, pp. 479-485
-
-
Giaffer, H.1
Holdsworth, C.D.2
Lennard-Jones, J.E.3
-
74
-
-
34447493368
-
Relapse prevention of ulcerative colitis: Double-blind comparison of 1.5 gram vs 3 gram oral mesalazine (Pentasa)
-
abstract
-
Fockens P, Mulder CJJ, Ferwerda J, et al. Relapse prevention of ulcerative colitis: Double-blind comparison of 1.5 gram vs 3 gram oral mesalazine (Pentasa). Gastroenterology 1993;104:A701 (abstract).
-
(1993)
Gastroenterology
, vol.104
-
-
Fockens, P.1
Mulder, C.J.J.2
Ferwerda, J.3
-
75
-
-
0001579068
-
Maintenance of remission of ulcerative colitis by mesalamine (Asacol) versus placebo
-
abstract
-
Hanauer S, Powers B, Robinson M, et al. Maintenance of remission of ulcerative colitis by mesalamine (Asacol) versus placebo. Gastroenterology 1994;106:A696 (abstract).
-
(1994)
Gastroenterology
, vol.106
-
-
Hanauer, S.1
Powers, B.2
Robinson, M.3
-
76
-
-
15844361997
-
Double-blind dose-finding study of olsalazine vs sulfasalazine for maintenance therapy of ulcerative colitis
-
Kruis W, Judmaier G, Kayasseh L, et al. Double-blind dose-finding study of olsalazine vs sulfasalazine for maintenance therapy of ulcerative colitis (abstract). Gastroenterology 1992;102:A649.
-
(1992)
Gastroenterology
, vol.102
-
-
Kruis, W.1
Judmaier, G.2
Kayasseh, L.3
-
77
-
-
0026671294
-
Comparison of two doses of balsalazide in maintaining ulcerative colitis in remission over 12 months
-
Green JRB, Swan CHJ, Rowlinson A, et al. Comparison of two doses of balsalazide in maintaining ulcerative colitis in remission over 12 months. Aliment Pharmacol Ther 1992;6:647-52.
-
(1992)
Aliment Pharmacol Ther
, vol.6
, pp. 647-652
-
-
Green, J.R.B.1
Swan, C.H.J.2
Rowlinson, A.3
-
78
-
-
0016157704
-
Intensive intravenous regimen for severe attacks of ulcerative colitis
-
Truelove SC, Jewell D. Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet 1974;1:1067-70.
-
(1974)
Lancet
, vol.1
, pp. 1067-1070
-
-
Truelove, S.C.1
Jewell, D.2
-
79
-
-
0018159293
-
Further experience in the treatment of severe attacks of ulcerative colitis
-
Truelove SC, Willoughby CP, Lee G, et al. Further experience in the treatment of severe attacks of ulcerative colitis. Lancet 1978;2:1086-8.
-
(1978)
Lancet
, vol.2
, pp. 1086-1088
-
-
Truelove, S.C.1
Willoughby, C.P.2
Lee, G.3
-
81
-
-
0022505628
-
Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in ulcerative colitis
-
Chapman RW, Selby WS, Jewell DP. Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in ulcerative colitis. Gut 1986;27:1210-2.
-
(1986)
Gut
, vol.27
, pp. 1210-1212
-
-
Chapman, R.W.1
Selby, W.S.2
Jewell, D.P.3
-
82
-
-
0020560387
-
Corticotropin vs hydrocortisone in the intravenous treatment of ulcerative colitis
-
Meyers S, Sachar DB, Goldberg JD, et al. Corticotropin vs hydrocortisone in the intravenous treatment of ulcerative colitis. Gastroenterology 1983;85:351-7.
-
(1983)
Gastroenterology
, vol.85
, pp. 351-357
-
-
Meyers, S.1
Sachar, D.B.2
Goldberg, J.D.3
-
83
-
-
0016800127
-
A controlled evaluation of intravenous adrenocorticotropic hormone and hydrocortisone in the treatment of acute colitis
-
Kaplan HP, Portnoy B, Binder HJ, et al. A controlled evaluation of intravenous adrenocorticotropic hormone and hydrocortisone in the treatment of acute colitis. Gastroenterology 1975;69:91-5.
-
(1975)
Gastroenterology
, vol.69
, pp. 91-95
-
-
Kaplan, H.P.1
Portnoy, B.2
Binder, H.J.3
-
84
-
-
0017566640
-
A controlled comparison of corticotropin and hydrocortisone in the treatment of severe proctocolitis
-
Powell-Tuck J, Bucknell NA, Lennard-Jones JE. A controlled comparison of corticotropin and hydrocortisone in the treatment of severe proctocolitis. Scand J Gastroenterol 1977;12:971-5.
-
(1977)
Scand J Gastroenterol
, vol.12
, pp. 971-975
-
-
Powell-Tuck, J.1
Bucknell, N.A.2
Lennard-Jones, J.E.3
-
85
-
-
0025020698
-
High-dose methylprednisone in the treatment of active ulcerative colitis
-
Rosenberg W, Ireland A, Jewell D. High-dose methylprednisone in the treatment of active ulcerative colitis. J Clin Gastroenterol 1990; 12:40-1.
-
(1990)
J Clin Gastroenterol
, vol.12
, pp. 40-41
-
-
Rosenberg, W.1
Ireland, A.2
Jewell, D.3
-
86
-
-
0022392051
-
Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis
-
Dickinson RJ, O'Connor HJ, Pinder I, et al. Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis. Gut 1985;26:1380-4.
-
(1985)
Gut
, vol.26
, pp. 1380-1384
-
-
Dickinson, R.J.1
O'Connor, H.J.2
Pinder, I.3
-
87
-
-
0019142004
-
Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis
-
Dickinson RJ, Ashton MG, Axon ATR, et al. Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis. Gastroenterology 1980;79:1199-2004.
-
(1980)
Gastroenterology
, vol.79
, pp. 1199-2004
-
-
Dickinson, R.J.1
Ashton, M.G.2
Axon, A.T.R.3
-
88
-
-
0022516491
-
Controlled trial of bowel rest in the treatment of severe acute colitis
-
McIntyre DB, Powell-Tuck J, Wood SR. Controlled trial of bowel rest in the treatment of severe acute colitis. Gut 1986;27:481-5.
-
(1986)
Gut
, vol.27
, pp. 481-485
-
-
McIntyre, D.B.1
Powell-Tuck, J.2
Wood, S.R.3
-
89
-
-
0025084319
-
The starved colon-diminished mucosal nutrition, diminished absorption and colitis
-
Roediger WE. The starved colon-diminished mucosal nutrition, diminished absorption and colitis. Dis Colon Rectum 1990;33:858-62.
-
(1990)
Dis Colon Rectum
, vol.33
, pp. 858-862
-
-
Roediger, W.E.1
-
90
-
-
4043161587
-
The treatment of severe ulcerative and Crohn's colitis: A critical analysis of the defined trials
-
Kornbluth A, Marion J, Bharuca S, et al. The treatment of severe ulcerative and Crohn's colitis: A critical analysis of the defined trials. J Clin Gastroenterol 1995;18:242-6.
-
(1995)
J Clin Gastroenterol
, vol.18
, pp. 242-246
-
-
Kornbluth, A.1
Marion, J.2
Bharuca, S.3
-
91
-
-
0028292007
-
Cyclosporine in severe ulcerative colitis refractory to steroid therapy
-
Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994; 330:1841-5.
-
(1994)
N Engl J Med
, vol.330
, pp. 1841-1845
-
-
Lichtiger, S.1
Present, D.H.2
Kornbluth, A.3
-
92
-
-
0001288489
-
Long term results of oral cyclosporine in patients with severe ulcerative colitis: A double-blind, randomized, multi-center trial
-
abstract
-
Kornbluth A, Lichtiger S, Present DH, et al. Long term results of oral cyclosporine in patients with severe ulcerative colitis: A double-blind, randomized, multi-center trial. Gastroenterology 1994;106(2): A714 (abstract).
-
(1994)
Gastroenterology
, vol.106
, Issue.2
-
-
Kornbluth, A.1
Lichtiger, S.2
Present, D.H.3
-
94
-
-
0027458081
-
Toxic megacolon: The knee-elbow position relieves bowel distension
-
Panos MS, Wood MJ, Asquith P. Toxic megacolon: The knee-elbow position relieves bowel distension. Gut 1993;34:1726-7.
-
(1993)
Gut
, vol.34
, pp. 1726-1727
-
-
Panos, M.S.1
Wood, M.J.2
Asquith, P.3
-
96
-
-
0014483588
-
Fate of the rectum and distal colon after subtotal colectomy for ulcerative colitis
-
Korelitz BI, Dyck WP, Klion FM. Fate of the rectum and distal colon after subtotal colectomy for ulcerative colitis. Gut 1969;10:198-201.
-
(1969)
Gut
, vol.10
, pp. 198-201
-
-
Korelitz, B.I.1
Dyck, W.P.2
Klion, F.M.3
-
97
-
-
0025293943
-
Management of severe hemorrhage in ulcerative colitis
-
Robert JH, Sachar DB, Aufses AH, et al. Management of severe hemorrhage in ulcerative colitis. Am J Surg 1990;159:550-5.
-
(1990)
Am J Surg
, vol.159
, pp. 550-555
-
-
Robert, J.H.1
Sachar, D.B.2
Aufses, A.H.3
-
99
-
-
0022361675
-
Surveillance for colorectal cancer in ulcerative colitis
-
Rosenstock E, Farmer RG, Petras R, et al. Surveillance for colorectal cancer in ulcerative colitis. Gastroenterology 1985;89:1342.
-
(1985)
Gastroenterology
, vol.89
, pp. 1342
-
-
Rosenstock, E.1
Farmer, R.G.2
Petras, R.3
-
101
-
-
0019379322
-
Dysplasia associated lesion or mass (DALM) detected by colonoscopy in longstanding ulcerative colitis: An indication for colectomy
-
Blackstone M, Riddell RW, Rogers BHG, et al. Dysplasia associated lesion or mass (DALM) detected by colonoscopy in longstanding ulcerative colitis: An indication for colectomy. Gastroenterology 1981;80:366-74.
-
(1981)
Gastroenterology
, vol.80
, pp. 366-374
-
-
Blackstone, M.1
Riddell, R.W.2
Bhg, R.3
-
102
-
-
0026777059
-
Benign and malignant colorectal strictures in ulcerative colitis
-
Gumaste V, Sachar DB, Greenstein AJ. Benign and malignant colorectal strictures in ulcerative colitis. Gut 1992;33:938-41.
-
(1992)
Gut
, vol.33
, pp. 938-941
-
-
Gumaste, V.1
Sachar, D.B.2
Greenstein, A.J.3
-
103
-
-
0028057219
-
Adenocarcinoma in strictures of ulcerative colitis without antecedent dysplasia by colonoscopy
-
Reiser JR, Waye JD, Janowitz HD, et al. Adenocarcinoma in strictures of ulcerative colitis without antecedent dysplasia by colonoscopy. Am J Gastroenterol 1994;89:119-22.
-
(1994)
Am J Gastroenterol
, vol.89
, pp. 119-122
-
-
Reiser, J.R.1
Waye, J.D.2
Janowitz, H.D.3
-
104
-
-
0028126001
-
Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis
-
Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis. Lancet 1994;343:71-4.
-
(1994)
Lancet
, vol.343
, pp. 71-74
-
-
Bernstein, C.N.1
Shanahan, F.2
Weinstein, W.M.3
-
105
-
-
0028064988
-
Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis
-
Connell WR, Lennard-Jones JE, Williams CB, et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994;107:934-44.
-
(1994)
Gastroenterology
, vol.107
, pp. 934-944
-
-
Connell, W.R.1
Lennard-Jones, J.E.2
Williams, C.B.3
-
106
-
-
0026634758
-
Surveillance in the routine management of ulcerative colitis: The predictive value of low grade dysplasia
-
Woolrich AJ, DaSilva MD, Korelitz BI. Surveillance in the routine management of ulcerative colitis: The predictive value of low grade dysplasia. Gastroenterology 1992;103:431-8.
-
(1992)
Gastroenterology
, vol.103
, pp. 431-438
-
-
Woolrich, A.J.1
DaSilva, M.D.2
Korelitz, B.I.3
-
107
-
-
0020582146
-
Does intestinal resection heal the pyoderma of inflammatory bowel disease?
-
Talansky A, Meyers S, Greenstein AJ, et al. Does intestinal resection heal the pyoderma of inflammatory bowel disease? J Clin Gastroenterol 1983;5:207-10.
-
(1983)
J Clin Gastroenterol
, vol.5
, pp. 207-210
-
-
Talansky, A.1
Meyers, S.2
Greenstein, A.J.3
-
108
-
-
0018405402
-
Autoimmune hemolytic anemia in ulcerative colitis
-
Altman AR, Maltz CR, Janowitz HD. Autoimmune hemolytic anemia in ulcerative colitis. Dig Dis Sci 1979;24:282-5.
-
(1979)
Dig Dis Sci
, vol.24
, pp. 282-285
-
-
Altman, A.R.1
Maltz, C.R.2
Janowitz, H.D.3
-
109
-
-
0015037829
-
Autoimmune hemolytic anemia in ulcerative colitis cured by colectomy
-
Arner O. Autoimmune hemolytic anemia in ulcerative colitis cured by colectomy. Acta Med Scand 1971;189:275-8.
-
(1971)
Acta Med Scand
, vol.189
, pp. 275-278
-
-
Arner, O.1
-
110
-
-
0018357266
-
Cancer in ulcerative and left-sided ulcerative colitis: Factors determining risk
-
Greenstein AJ, Sachar DB, Smith H, et al. Cancer in ulcerative and left-sided ulcerative colitis: Factors determining risk. Gastroenterology 1979;77:290-4.
-
(1979)
Gastroenterology
, vol.77
, pp. 290-294
-
-
Greenstein, A.J.1
Sachar, D.B.2
Smith, H.3
-
111
-
-
0025979693
-
Colorectal cancer in ulcerative colitis: Influence of anatomical extent and age at onset on colitis-cancer interval
-
Sugita A, Sachar DB, Bodian C, et al. Colorectal cancer in ulcerative colitis: Influence of anatomical extent and age at onset on colitis-cancer interval. Gut 1991;32:167-9.
-
(1991)
Gut
, vol.32
, pp. 167-169
-
-
Sugita, A.1
Sachar, D.B.2
Bodian, C.3
-
112
-
-
0023907386
-
Colorectal cancer in patients with ulcerative colitis: A population study in central Israel
-
Gilat T, Fireman Z, Grossman A, et al. Colorectal cancer in patients with ulcerative colitis: A population study in central Israel. Gastroenterology 1988;94:870-7.
-
(1988)
Gastroenterology
, vol.94
, pp. 870-877
-
-
Gilat, T.1
Fireman, Z.2
Grossman, A.3
-
113
-
-
4043168684
-
Cancer risk in inflammatory bowel disease: Myths and Metaphors
-
Riddel RH, ed. New York: Elsevier
-
Sachar DB. Cancer risk in inflammatory bowel disease: Myths and Metaphors. In: Riddel RH, ed. Dysplasia and cancer in colitis. New York: Elsevier, 1991, pp 5-9.
-
(1991)
Dysplasia and Cancer in Colitis
, pp. 5-9
-
-
Sachar, D.B.1
-
114
-
-
0018425634
-
Cancer in universal and left-sided ulcerative colitis: Clinical and pathological features
-
Greenstein AJ, Sachar DB, Pucillo A, et al. Cancer in universal and left-sided ulcerative colitis: Clinical and pathological features. Mt Sinai J Med 1979;46:25-32.
-
(1979)
Mt Sinai J Med
, vol.46
, pp. 25-32
-
-
Greenstein, A.J.1
Sachar, D.B.2
Pucillo, A.3
-
115
-
-
0023856775
-
Colorectal cancer in ulcerative colitis: A cohort study of primary referrals from three centers
-
Gyde SN, Prior P, Allan RN, et al. Colorectal cancer in ulcerative colitis: A cohort study of primary referrals from three centers. Gut 1988;29:206-17.
-
(1988)
Gut
, vol.29
, pp. 206-217
-
-
Gyde, S.N.1
Prior, P.2
Allan, R.N.3
-
116
-
-
0022653273
-
Comparison of multiple synchronous colorectal cancers in ulcerative colitis, familial polyposis coli, and de novo cancer
-
Greenstein AJ, Slater G, Heimann TM, et al. Comparison of multiple synchronous colorectal cancers in ulcerative colitis, familial polyposis coli, and de novo cancer. Ann Surg 1986;203:123-8.
-
(1986)
Ann Surg
, vol.203
, pp. 123-128
-
-
Greenstein, A.J.1
Slater, G.2
Heimann, T.M.3
-
117
-
-
0027981530
-
Cancer surveillance in ulcerative colitis: More of the same or progress?
-
Vemulapalli R, Lance P. Cancer surveillance in ulcerative colitis: More of the same or progress? Gastroenterology 1994;107:1196-9.
-
(1994)
Gastroenterology
, vol.107
, pp. 1196-1199
-
-
Vemulapalli, R.1
Lance, P.2
-
118
-
-
0024396703
-
Hazard rates for dysplasia and cancer in ulcerative colitis: Results from a surveillance program
-
Lashner BA, Silverstein MD, Hanauer SB. Hazard rates for dysplasia and cancer in ulcerative colitis: Results from a surveillance program. Dig Dis Sci 1989;10:1536-41.
-
(1989)
Dig Dis Sci
, vol.10
, pp. 1536-1541
-
-
Lashner, B.A.1
Silverstein, M.D.2
Hanauer, S.B.3
-
119
-
-
0024465973
-
Observer study of the grading of dysplasia in ulcerative colitis: Comparison with clinical outcome
-
Melville DM, Jass JR, Morson BC, et al. Observer study of the grading of dysplasia in ulcerative colitis: Comparison with clinical outcome. Hum Pathol 1989;20:1008-14.
-
(1989)
Hum Pathol
, vol.20
, pp. 1008-1014
-
-
Melville, D.M.1
Jass, J.R.2
Morson, B.C.3
|